Sulfhydryl Cross-linked Targeted Gene Delivery
Sulfhydryl Cross-linked Targeted Gene Delivery
批准号:
6995363
负责人:
KEVIN G RICE
金额:
$21.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-01-01 至 2008-05-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This study will investigate a novel gene delivery system that is based on the formation of sulfhydryl crosslinks within peptide DNA condensates. The gene delivery system under investigation is a multi-component peptide condensed DNA formulation. The key components consist of plasmid DNA condensed by an addmixture of peptide conjugates each containing multiple sulfhydryl groups designed to spontaneously polymerize and cross-link when bound to DNA. Following i.v. dosing, cross-linked DNA condensates are proposed to transiently stabilize plasmid DNA during circulation and inside the target cells. Cross-linking peptides will be covalently derivatized with a single polyethylene glycol (PEG) chain to form a steric layer on the surface of DNA condensates that blocks protein binding and masks DNA condensate recognition by the reticuloendothelial system. Targeting specificity will be achieved by derivatizing a cross-linking peptide with a single N-glycan resulting in glycopeptides that direct targeting to either the asialoglycoprotein receptor on hepatocytes or the mannose receptor on Kupffer cells. DNA condensates will be prepared using binary addmixtures of cross-linking glycopeptide and PEG-peptide. Cross-linking peptides will be modified to buffer endosomes and allow DNA condensates to release into the cytosol of target cells. Once in the cytosol, crosslinked DNA condensates are proposed to slowly release plasmid DNA following disulfide bond reduction. The central hypothesis to be tested is that increasing DNA condensate stability and controlling the rate of DNA release into the cytosol will prolong the half-life of DNA and produce higher levels of gene expression in vivo. These studies aim to systematically optimize the level of transient gene expression in vivo using a novel chemical mechanism to overcome barriers that currently limit the efficiency of nonviral gene delivery systems.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Targeted Double Stranded mRNA Nanoparticles
-
批准号:9335928
-
项目类别:
-
资助金额:$30.12万
-
财政年份:2016
-
负责人:KEVIN G RICE
-
依托单位:
Targeted Double Stranded mRNA Nanoparticles
-
批准号:9523296
-
项目类别:
-
资助金额:$30.12万
-
财政年份:2016
-
负责人:KEVIN G RICE
-
依托单位:
Polyacridine Peptide Mediated Gene Targeting
-
批准号:8193314
-
项目类别:
-
资助金额:$28.39万
-
财政年份:2011
-
负责人:KEVIN G RICE
-
依托单位:
Polyacridine Peptide Mediated Gene Targeting
-
批准号:8306000
-
项目类别:
-
资助金额:$28.39万
-
财政年份:2011
-
负责人:KEVIN G RICE
-
依托单位:
Polyacridine Peptide Mediated Gene Targeting
-
批准号:8447530
-
项目类别:
-
资助金额:$27.39万
-
财政年份:2011
-
负责人:KEVIN G RICE
-
依托单位:
High Throughput Drug Screening Robot
-
批准号:7839322
-
项目类别:
-
资助金额:$72.97万
-
财政年份:2011
-
负责人:KEVIN G RICE
-
依托单位:
Polyacridine Peptide Mediated Gene Targeting
-
批准号:8628847
-
项目类别:
-
资助金额:$28.39万
-
财政年份:2011
-
负责人:KEVIN G RICE
-
依托单位:
RAMP Mediated Gene Delivery
-
批准号:7896643
-
项目类别:
-
资助金额:$31.19万
-
财政年份:2009
-
负责人:KEVIN G RICE
-
依托单位:
RAMP Mediated Gene Delivery
-
批准号:8116557
-
项目类别:
-
资助金额:$30.87万
-
财政年份:2009
-
负责人:KEVIN G RICE
-
依托单位:
RAMP Mediated Gene Delivery
-
批准号:8307721
-
项目类别:
-
资助金额:$30.87万
-
财政年份:2009
-
负责人:KEVIN G RICE
-
依托单位:
Proteosome Inhibitor Enhanced Non-Viral Gene Delivery
-
批准号:7039140
-
项目类别:
-
资助金额:$21.61万
-
财政年份:2005
-
负责人:KEVIN G RICE
-
依托单位:
Proteosome Inhibitor Enhanced Non-Viral Gene Delivery
-
批准号:7474879
-
项目类别:
-
资助金额:$4.57万
-
财政年份:2005
-
负责人:KEVIN G RICE
-
依托单位:
Proteosome Inhibitor Enhanced Non-Viral Gene Delivery
-
批准号:7279038
-
项目类别:
-
资助金额:$4.55万
-
财政年份:2005
-
负责人:KEVIN G RICE
-
依托单位:
Proteosome Inhibitor Enhanced Non-Viral Gene Delivery
-
批准号:7213374
-
项目类别:
-
资助金额:$25.4万
-
财政年份:2005
-
负责人:KEVIN G RICE
-
依托单位:
Proteosome Inhibitor Enhanced Non-Viral Gene Delivery
-
批准号:7390819
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2005
-
负责人:KEVIN G RICE
-
依托单位:
Proteasome Inhibitor Enhanced Non-Viral Gene Delivery
-
批准号:6925752
-
项目类别:
-
资助金额:$22.13万
-
财政年份:2005
-
负责人:KEVIN G RICE
-
依托单位:
Sulfhydryl Cross-linked Targeted Gene Delivery
-
批准号:6829646
-
项目类别:
-
资助金额:$22.13万
-
财政年份:2003
-
负责人:KEVIN G RICE
-
依托单位:
Sulfhydryl Cross-linked Targeted Gene Delivery
-
批准号:6691662
-
项目类别:
-
资助金额:$22.13万
-
财政年份:2003
-
负责人:KEVIN G RICE
-
依托单位:
Sulfhydryl Cross-linked Targeted Gene Delivery
-
批准号:6562553
-
项目类别:
-
资助金额:$22.09万
-
财政年份:2003
-
负责人:KEVIN G RICE
-
依托单位:
REGULATED OSTEOINDUCTIVE PLASMID GENE TRANSFER VIA GENE
-
批准号:2897232
-
项目类别:
-
资助金额:$30.5万
-
财政年份:1998
-
负责人:KEVIN G RICE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
胰岛素样生长信号介导的肺巨噬细胞和上皮细胞cross-tolk通过核自噬参与慢性气道炎症形成的机制研究
-
批准号:JCZRYB202500229
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
基于NLRP3炎性小体与自噬Cross-talk探讨心康冲剂干预心肌纤维化的机制研究
-
批准号:2025JJ80174
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:邹菊英
-
依托单位:
PKM2琥珀酰化修饰介导癌细胞与血小板间Cross-talk调控胆管癌侵袭转移的研究
-
批准号:JCZRYB202500379
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
基于破骨-成骨细胞Cross-Talk探讨内固定物存留对关节软骨退变的影响及补肾强骨治法的科学内涵
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
三痹汤激活线粒体自噬影响免疫细胞Cross talk延缓椎间盘退变的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:王楠
-
依托单位:
多环芳烃(PAHs )介导的癌细胞和Th17细胞“cross-talk”所
致免疫抑制反应在胶质瘤增殖侵袭中的作用及毒理学机制研
究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
PGK1乙酰化修饰介导癌细胞与TAMs间Cross-talk调控胆囊癌EMT的研究
-
批准号:82373032
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:王剑明
-
依托单位:
线粒体ClpP激动剂通过铁死亡-免疫调控cross-talk治疗急性髓细胞白血病的机制研究
-
批准号:82370171
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:吴俣
-
依托单位:
生长激素受体通过脂肪酸介导的肝脏-脂肪Cross-talk影响脂质内稳态的研究
-
批准号:82370866
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:吴英杰
-
依托单位:
基于“cross-β折叠”结构形成理论解析面筋蛋白淀粉样纤维的形成机制
-
批准号:32372365
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:张慧娟
-
依托单位: